Carisma Therapeutics
  • About UsOpenClose
    • LeadershipOpenClose
    • BoardOpenClose
  • TechnologyOpenClose
    • PublicationsOpenClose
  • PipelineOpenClose
    • CT – 0508OpenClose
  • For PatientsOpenClose
  • NewsroomOpenClose
    • Media CoverageOpenClose
    • Press ReleasesOpenClose
  • Careers
  • Contact Us

Press releases

The latest news and company updates

First-of-its-kind Engineered Macrophage Cell Therapy Platform Shows Ability to Reduce Tumor Burden and Activate Anti-Tumor Immunity, Improving Overall Survival in Pre-Clinical Cancer Models

March 23, 2020

Study highlights previously untapped potential of genetically engineered macrophages in immunotherapy for solid tumors.

Carisma Therapeutics to Present at March Scientific and Investor Conferences

March 2, 2020

Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two conferences in March, 2020.

Carisma Therapeutics Expands Leadership Team

January 6, 2020

Carisma Therapeutics expands leadership with appointments of Debora Barton, MD as Chief Medical Officer, and Tom Wilton as Chief Business Officer.

Carisma Therapeutics Presents Data at the AACR Tumor Immunology and Immunotherapy Meeting 2019

November 18, 2019

Carisma Therapeutics Senior Scientist Konrad Gabrusiewicz, PhD, will present an abstract titled "CT-0508, a novel CAR macrophage product directed against HER2, promotes a pro-inflammatory tumor microenvironment" at the AACR Tumor Immunology and Immunotherapy 2019 meeting taking place November 17-20 in Boston, MA.

Carisma Therapeutics Announces Investor Conference Participation

November 16, 2019

Carisma Therapeutics announced today that it will be participating in three upcoming investor conferences.

Carisma Shares Unique Engineered Macrophage Cell Therapy Approach at the Inaugural Macrophage-Directed Therapies Summit

October 21, 2019

Carisma's VP of Business Development, Dora Mitchell, PhD and VP of Discovery Research, Michael Klichinsky, PharmD, PhD chaired and presented at the inaugural macrophage-directed therapies summit taking place October 22-24, 2019 in Boston, MA.

1 2 3 4 5 6 7 8 9 10
  • Carisma Therapeutics
    Connect with Carisma
    • LinkedIn
    • Twittter
    • Facebook
  • About Us
    • Leadership
    • Board
  • Technology
    • Publications
  • Pipeline
    • CT – 0508
  • For Patients
  • Newsroom
    • Media Coverage
    • Press Releases
  • © Carisma Therapeutics, Inc. 2022
  • Privacy Policy